World Federation of Hemophilia
-
Roche outlines plan for communicating new findings on emicizumab (Hemlibra)
In a letter to the global hemophilia community, Roche describes its plan for keeping healthcare professionals and patients informed of new efficacy and safety data...
-
WFH Advisory: availability of desmopressin pending re-start of intranasal desmopressin manufacture
Update to WFH Notice: Global recall of Octim®/Octostim® desmopressin nasal spray (1.5 mg/ml) by Ferring Pharmaceuticals With ongoing investigation following the mid-July global recall of...
-
Roche/Genentech Update on Particles Identified in emicizumab (Hemlibra)
Roche and Genentech have announced an update on measures being taken in relation to the translucent silicon oil and protein particles that were identified in...
-
Update on FDA approval for valoctocogene roxaparvovec gene therapy for severe hemophilia A
A statement was released by BioMarin regarding the status of the U.S. Food and Drug Administration (FDA) approval process for valoctocogene roxaparvovec gene therapy for...
-
WFH Notice: Global recall of Octim®/Octostim® desmopressin nasal spray (1.5 mg/ml) by Ferring Pharmaceuticals
Update to WFH Notice: recall of desmopressin nasal spray by Ferring Pharmaceuticals (July 20, 2020) August 4, 2020 In mid-July, Ferring Pharmaceuticals initiated a voluntary precautionary...
-
WFH Notice: recall of desmopressin nasal spray by Ferring Pharmaceuticals
July 20, 2020 The WFH has learned of a voluntary product recall of desmopressin nasal spray by Ferring Pharmaceuticals, due to out of specification results...
-
Sanofi and Sobi pledge an additional 500 million IUs of clotting factor to WFH Humanitarian Aid Program
Sanofi and Sobi, have announced an extension of their support of the WFH Humanitarian Aid Program with an additional donation of up to 500 million...
-
Joint WFH and NHF statement issued regarding two deaths reported in orphan disease gene therapy clinical trial
A joint World Federation of Hemophilia (WFH) and National Hemophilia Foundation (NHF) statement* is issued on two deaths reported in orphan disease gene therapy clinical...
-
Today’s schedule: sessions at the WFH Virtual Summit on June 19
Here are the sessions happening today at the WFH Virtual Summit. For more information, please click here. 09:00 – 10:00 General Plenary: Managing COVID-19 and...
-
Join us at our Roche virtual exhibition booth
Join us at our Roche virtual exhibition booth
